alutard sq dermatophagoides farinae stungulääke dreifa stungulääke d - etsinnän tulokset

amicus therapeutics europe limited - cipaglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

hydroxocobalamin g.l. pharma (hydroxocobalamin pharmexon 1 mg/ml stungulyf, lausn) stungulyf, lausn 1 mg/ml

g.l. pharma gmbh - hydroxocobalaminum acetat - stungulyf, lausn - 1 mg/ml

Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

azacitidine zentiva stungulyfsstofn, dreifa 25 mg/ml

zentiva k.s.* - stungulyfsstofn, dreifa - 25 mg/ml

Euroopan unioni - islanti - EMA (European Medicines Agency)

bemfola

gedeon richter plc. - follitrópín alfa - anovulation - hormón kynlíf og stillum kynfæri - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. Í klínískum raunir þessar sjúklinga sem voru skilgreind af innræn blóðvatn ace stigi < 1. 2 ae / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.